See more : VIZSLA ROYALTIES CORP (VROY.V) Income Statement Analysis – Financial Results
Complete financial analysis of Beijing Scitop Bio-tech Co., Ltd. (300858.SZ) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Beijing Scitop Bio-tech Co., Ltd., a leading company in the Biotechnology industry within the Healthcare sector.
- Atari SA (PONGF) Income Statement Analysis – Financial Results
- Aries Agro Limited (ARIES.NS) Income Statement Analysis – Financial Results
- Guangzhou Hangxin Aviation Technology Co., Ltd. (300424.SZ) Income Statement Analysis – Financial Results
- Fwusow Industry Co., Ltd. (1219.TW) Income Statement Analysis – Financial Results
- TSC Auto ID Technology Co., Ltd. (3611.TWO) Income Statement Analysis – Financial Results
Beijing Scitop Bio-tech Co., Ltd. (300858.SZ)
About Beijing Scitop Bio-tech Co., Ltd.
Beijing Scitop Bio-tech Co., Ltd. develops, produces, and sells probiotic lactic acid bacteria and related products in China. It also provides compound food additives, edible probiotic products, and animal and plant microecological preparations. Its products have applications in the food industry, health care, animal husbandry, and agricultural planting. Beijing Scitop Bio-tech Co., Ltd. was founded in 2003 and is headquartered in Beijing, China.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | 299.24M | 369.17M | 364.62M | 339.16M | 308.10M | 317.90M | 283.76M | 260.62M | 185.41M |
| Cost of Revenue | 135.91M | 177.29M | 181.17M | 175.27M | 150.63M | 160.72M | 150.55M | 144.51M | 111.06M |
| Gross Profit | 163.33M | 191.88M | 183.45M | 163.88M | 157.46M | 157.17M | 133.20M | 116.11M | 74.35M |
| Gross Profit Ratio | 54.58% | 51.98% | 50.31% | 48.32% | 51.11% | 49.44% | 46.94% | 44.55% | 40.10% |
| Research & Development | 34.19M | 22.09M | 27.15M | 17.57M | 14.75M | 15.84M | 12.59M | 9.39M | 6.04M |
| General & Administrative | 2.51M | 7.63M | 15.78M | 6.34M | 4.65M | 7.26M | 5.99M | 65.88M | 13.18M |
| Selling & Marketing | 22.83M | 27.23M | 25.01M | 18.07M | 16.44M | 13.34M | 12.16M | 16.48M | 5.43M |
| SG&A | 25.35M | 34.86M | 40.79M | 24.41M | 21.09M | 20.61M | 18.16M | 82.35M | 18.61M |
| Other Expenses | 0.00 | -1.92M | -530.57K | -4.54M | -131.70K | -159.33K | -333.51K | 4.65M | 741.69K |
| Operating Expenses | 60.73M | 76.09M | 89.03M | 53.47M | 48.80M | 49.83M | 43.32M | 93.56M | 25.70M |
| Cost & Expenses | 196.64M | 253.38M | 270.19M | 228.74M | 199.43M | 210.55M | 193.87M | 238.07M | 136.76M |
| Interest Income | 24.00M | 3.64M | 6.74M | 3.50M | 156.89K | 311.63K | 149.77K | 3.30M | 1.28M |
| Interest Expense | 548.24K | 405.32K | 439.08K | 37.47K | 337.47K | 0.00 | 254.89K | 0.00 | 0.00 |
| Depreciation & Amortization | 20.34M | 18.22M | 16.52M | 10.58M | 5.83M | 2.22M | 2.19M | 1.28M | 2.93M |
| EBITDA | 123.92M | 144.75M | 128.34M | 124.27M | 116.80M | 109.12M | 91.84M | 24.75M | 49.45M |
| EBITDA Ratio | 41.41% | 39.19% | 35.20% | 36.14% | 37.37% | 35.25% | 32.73% | 8.30% | 26.67% |
| Operating Income | 102.60M | 127.58M | 124.70M | 117.71M | 110.72M | 107.06M | 87.84M | 20.12M | 46.52M |
| Operating Income Ratio | 34.29% | 34.56% | 34.20% | 34.71% | 35.94% | 33.68% | 30.95% | 7.72% | 25.09% |
| Total Other Income/Expenses | -560.66K | -1.92M | -530.57K | -4.54M | -131.70K | -159.33K | -333.51K | 4.65M | -594.63K |
| Income Before Tax | 102.04M | 125.66M | 124.17M | 113.18M | 110.58M | 106.90M | 87.50M | 24.77M | 47.27M |
| Income Before Tax Ratio | 34.10% | 34.04% | 34.06% | 33.37% | 35.89% | 33.63% | 30.84% | 9.50% | 25.49% |
| Income Tax Expense | 8.56M | 15.76M | 14.63M | 16.60M | 17.30M | 14.99M | 16.33M | 13.28M | 12.25M |
| Net Income | 93.48M | 109.89M | 109.54M | 96.58M | 93.28M | 91.92M | 71.35M | 11.54M | 35.02M |
| Net Income Ratio | 31.24% | 29.77% | 30.04% | 28.48% | 30.28% | 28.91% | 25.14% | 4.43% | 18.89% |
| EPS | 0.35 | 0.49 | 0.49 | 0.43 | 0.42 | 0.55 | 0.44 | 0.10 | 0.40 |
| EPS Diluted | 0.35 | 0.49 | 0.49 | 0.43 | 0.42 | 0.55 | 0.44 | 0.10 | 0.40 |
| Weighted Avg Shares Out | 267.09M | 223.39M | 222.80M | 222.80M | 222.80M | 166.57M | 163.25M | 119.79M | 88.36M |
| Weighted Avg Shares Out (Dil) | 267.09M | 223.39M | 222.80M | 222.80M | 222.80M | 166.57M | 163.25M | 119.79M | 88.36M |
Source: https://incomestatements.info
Category: Stock Reports